MT-ND4 and Leber hereditary optic neuropathy: The preclinical study of ND4 gene therapy for Leber hereditary optic neuropathy had been completed (Yu et al. 2012), and the clinical trials of ND4 gene therapy have been conducted (Koilkonda et al. 2014).